v3.26.1
Segment financial information - adjusted operating income (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment financial information        
Net sales $ 1,692.3 $ 1,683.4 $ 3,273.7 $ 3,264.8
Adjusted cost of goods and services sold 1,154.6 1,129.1 2,235.2 2,175.5
Adjusted operating expenses 312.6 302.1 622.8 594.3
Adjusted Operating Income 225.1 252.2 415.7 495.0
Adjusted cost of sales, non-GAAP adjustments 0.7 0.2 0.8 0.3
Adjusted operating expenses, non-GAAP adjustments 102.6 123.2 193.6 218.5
Bioscience & Medtech Products        
Segment financial information        
Net sales 451.8 475.9 883.2 902.3
VWR Distribution & Services        
Segment financial information        
Net sales 1,240.5 1,207.5 2,390.5 2,362.5
Operating Segments | Bioscience & Medtech Products        
Segment financial information        
Net sales 451.8 475.9 883.2 902.3
Adjusted cost of goods and services sold 231.9 242.8 458.6 458.2
Adjusted operating expenses 102.3 101.7 204.3 198.2
Adjusted Operating Income 117.6 131.4 220.3 245.9
Operating Segments | VWR Distribution & Services        
Segment financial information        
Net sales 1,240.5 1,207.5 2,390.5 2,362.5
Adjusted cost of goods and services sold 922.7 886.3 1,776.6 1,717.3
Adjusted operating expenses 191.4 179.6 382.1 355.7
Adjusted Operating Income 126.4 141.6 231.8 289.5
Corporate        
Segment financial information        
Net sales 0.0 0.0 0.0 0.0
Adjusted cost of goods and services sold 0.0 0.0 0.0 0.0
Adjusted operating expenses 18.9 20.8 36.4 40.4
Adjusted Operating Income $ (18.9) $ (20.8) $ (36.4) $ (40.4)